Cargando…

Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.

Overexpression of the epidermal growth factor receptor (EGFR) and ErbB-2 has been observed in a variety of human tumours, making these receptors promising targets for directed tumour therapy. Since many tumour cells express both ErbB-2 and EGFR and these receptors synergise in cellular transformatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, M., Wels, W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074730/ https://www.ncbi.nlm.nih.gov/pubmed/8826849

Ejemplares similares

Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy
por: Zhou, Shu-juan, et al.
Publicado: (2017)

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)

EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies
por: Cooke, Heather A., et al.
Publicado: (2018)

Construction and expression of D-dimer and GPIIb/IIIa single-chain bispecific antibody
por: DAN, ZHAOKUI, et al.
Publicado: (2013)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
por: Azria, D, et al.
Publicado: (2003)

Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications
por: Compte, Marta, et al.
Publicado: (2014)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
por: Weth, R, et al.
Publicado: (2004)

Engineering Bispecificity into a Single Albumin-Binding Domain
por: Nilvebrant, Johan, et al.
Publicado: (2011)

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
por: Li, Cheng, et al.
Publicado: (2022)

Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
por: Li, Tianye, et al.
Publicado: (2023)

A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking
por: Herrera, Cristina, et al.
Publicado: (2016)

Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody
por: Hao, Chao-hui, et al.
Publicado: (2015)

Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow
por: Ahamadi-Fesharaki, Raoufeh, et al.
Publicado: (2019)

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody
por: Würdinger, T, et al.
Publicado: (2005)

Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach
por: Schaller, Teilo H, et al.
Publicado: (2020)

Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats
por: Madsen, Andreas V., et al.
Publicado: (2023)

Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach
por: Tkaczyk, C., et al.
Publicado: (2017)

Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
por: Benedetti, Filippo, et al.
Publicado: (2021)

455. Targeting of a Non-Human Coronavirus to Human Tumor Cells by Using a Bispecific Single-Chain Antibody
Publicado: (2003)

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
por: Liu, Delong, et al.
Publicado: (2019)

Characterization of light chain c-terminal extension sequence variant in one bispecific antibody
por: Lin, Jun, et al.
Publicado: (2022)

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.
por: Harwerth, I. M., et al.
Publicado: (1993)

Design and Production of Bispecific Antibodies
por: Wang, Qiong, et al.
Publicado: (2019)

Bispecific Antibodies for Diagnostic Applications
por: Parashar, Archana, et al.
Publicado: (2011)

Bispecific Antibodies and Gene Therapy
por: Nettelbeck, Dirk M.
Publicado: (2011)

Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)
por: Hurley, Kate, et al.
Publicado: (2023)

A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species
por: Stutz, Cian, et al.
Publicado: (2020)

Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies
por: Chen, Serene W., et al.
Publicado: (2020)

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
por: Niu, Mengke, et al.
Publicado: (2023)

Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
por: Van Blarcom, Thomas, et al.
Publicado: (2017)

CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022)

Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.
por: Schmidt, M., et al.
Publicado: (1997)

Tethered-variable C(L) bispecific IgG: an antibody platform for rapid bispecific antibody screening
por: Kim, Hok Seon, et al.
Publicado: (2017)

Intein mediated high throughput screening for bispecific antibodies
por: Hofmann, Tim, et al.
Publicado: (2020)

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
por: Van Hoecke, Lien, et al.
Publicado: (2020)

A Collection of Single-Domain Antibodies that Crowd Ricin Toxin’s Active Site
por: Angalakurthi, Siva Krishna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jiqre6vsvhtgm1av0i28mtnfp7